2004 Annual Meeting | Intra-arterial Thrombolysis for Acute Ischemic Stroke
| 06:45 AM - 06:55 AM | Introduction - Welcome | |
| 06:55 AM - 07:10 AM | Thombolytic Therapy for Acute Ischemic Stroke: Current Evidence Jose I. Suarez, MD, FAAN | |
| 07:10 AM - 07:30 AM | New Agents for Thrombolysis: The Third Generation Thrombolytics Hamza I. Maqsood, MD | |
| 07:30 AM - 07:50 AM | Post-Procedure Management and Complications of Intra-arterial Thrombolysis Camilo R. Gomez, MD, FAAN | |
| 07:50 AM - 08:30 AM | Discussion | 
| Jose I. Suarez, MD, FAAN | Dr. Suarez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Idorsia. Dr. Suarez has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for The Mayo Clinic. | 
| No disclosure on file | |
| Hamza I. Maqsood, MD | Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. | 
| Camilo R. Gomez, MD, FAAN | Dr. Gomez has nothing to disclose. |